Literature DB >> 24729987

H63D genotying for hemochromatosis: helper or hindrance?

Paul C Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24729987      PMCID： PMC4071924          DOI： 10.1155/2014/938025

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN： 2291-2789


× No keyword cloud information.
  8 in total

1.  Effect of ambiguous hemochromatosis gene test results on physician utilization.

Authors:  Mark Speechley; David Alter; Helen Guo; Helen Harrison; Paul C Adams
Journal:  Med Care       Date:  2012-05       Impact factor: 2.983

2.  The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Authors:  J N Feder; Z Tsuchihashi; A Irrinki; V K Lee; F A Mapa; E Morikang; C E Prass; S M Starnes; R K Wolff; S Parkkila; W S Sly; R C Schatzman
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

3.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells.

Authors:  A Waheed; S Parkkila; X Y Zhou; S Tomatsu; Z Tsuchihashi; J N Feder; R C Schatzman; R S Britton; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

4.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

5.  The natural history of untreated HFE-related hemochromatosis.

Authors:  Paul C Adams
Journal:  Acta Haematol       Date:  2009-11-10       Impact factor: 2.195

6.  HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  James S Pankow; Eric Boerwinkle; Paul C Adams; Eliseo Guallar; Catherine Leiendecker-Foster; Jason Rogowski; John H Eckfeldt
Journal:  Transl Res       Date:  2008-06-13       Impact factor: 7.012

7.  Iron overload is rare in patients homozygous for the H63D mutation.

Authors:  Melissa Kelley; Nikhil Joshi; Yagang Xie; Mark Borgaonkar
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

8.  Genetic screening for iron overload: No evidence of discrimination at 1 year.

Authors:  Mark A Hall; James C Barton; Paul C Adams; Christine E McLaren; Jacob A Reiss; Oswaldo Castro; Andrea Ruggiero; Ronald T Acton; Tara E Power; Thomas C Bent
Journal:  J Fam Pract       Date:  2007-10       Impact factor: 0.493
  8 in total
  4 in total

1.  The influence of non-HFE genes and steatohepatitis on increased iron stores in patients with the H63D mutation.

Authors:  Nevil Azzopardi
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb

2.  Examining the clinical use of hemochromatosis genetic testing.

Authors:  Matthew B Lanktree; Bruce B Lanktree; Guillaume Paré; John S Waye; Bekim Sadikovic; Mark A Crowther
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb

3.  Genetic diagnosis history and osteoarticular phenotype of a non-transfusion secondary hemochromatosis.

Authors:  Dan-Dan Ruan; Yu-Mian Gan; Tao Lu; Xiao Yang; Yao-Bin Zhu; Qing-Hua Yu; Li-Sheng Liao; Ning Lin; Xin Qian; Jie-Wei Luo; Fa-Qiang Tang
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

4.  The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic.

Authors:  Kathleen M Heath; Jacob H Axton; John M McCullough; Nathan Harris
Journal:  Am J Phys Anthropol       Date:  2016-01-22       Impact factor: 2.868
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.